↓ Skip to main content
Dove Medical Press
Article Metrics
What is this page?
Embed badge
Share
Share on Twitter
Share on Facebook
Share by email
Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash
Overview of attention for article published in Therapeutics and Clinical Risk Management, September 2015
Altmetric Badge
About this Attention Score
Average Attention Score compared to outputs of the same age
Mentioned by
twitter
3
X users
facebook
1
Facebook page
Readers on
mendeley
8
Mendeley
Summary
X
Facebook
So far, Altmetric has seen
1
public wall post.
Dove Medical Press,
07 Sep 2015
Lenalidomide discontinuation for rash in…